Larvol Delta - Amygdala-Neurosciences-announces-dosing-of-the-rst-patient-in-the-NIH-funded-phase-2-proofofconcept-study-of-ANS6637-for-the-treatment-of-alcohol-use-disorder

ANS-6637 - Amygdala Neurosci

https://www.prnewswire.com/news-releases/amygdala-neurosciences-announces-dosing-of-the-first-patient-in-the-nih-funded-phase-2-proof-of-concept-study-of-ans-6637-for-the-treatment-of-alcohol-use-disorder-300940134.html

Oct 17, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next